An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
Abstract Background Patient reported outcome measurements (PROMs) are emerging as an important component of patient management in the cancer setting, providing broad perspectives on patients’ quality of life and experience. The use of PROMs is, however, generally limited to the context of randomised...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Health and Quality of Life Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12955-020-01648-x |
id |
doaj-1e556adaa7314824be3bbfce3f9fb183 |
---|---|
record_format |
Article |
spelling |
doaj-1e556adaa7314824be3bbfce3f9fb1832021-01-17T12:19:10ZengBMCHealth and Quality of Life Outcomes1477-75252021-01-0119112010.1186/s12955-020-01648-xAn assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practiceMiss Charlotte L. Moss0Ajay Aggarwal1Asad Qureshi2Benjamin Taylor3Teresa Guerrero-Urbano4Mieke Van Hemelrijck5King’s College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), Guy’s HospitalComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustKing’s College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), Guy’s HospitalAbstract Background Patient reported outcome measurements (PROMs) are emerging as an important component of patient management in the cancer setting, providing broad perspectives on patients’ quality of life and experience. The use of PROMs is, however, generally limited to the context of randomised control trials, as healthcare services are challenged to sustain high quality of care whilst facing increasing demand and financial shortfalls. We performed a systematic review of the literature to identify any oncological benefit of using PROMs and investigate the wider impact on patient experience, in cancers of the pelvic abdominal cavity specifically. Methods A systematic review of the literature was conducted using MEDLINE (Pubmed) and Ovid Gateway (Embase and Ovid) until April 2020. Studies investigating the oncological outcomes of PROMs were deemed suitable for inclusion. Results A total of 21 studies were included from 2167 screened articles. Various domains of quality of life (QoL) were identified as potential prognosticators for oncologic outcomes in cancers of the pelvic abdominal cavity, independent of other clinicopathological features of disease: 3 studies identified global QoL as a prognostic factor, 6 studies identified physical and role functioning, and 2 studies highlighted fatigue. In addition to improved outcomes, a number of included studies also reported that the use of PROMs enhanced both patient-clinician communication and patient satisfaction with care in the clinical setting. Conclusions This review highlights the necessity of routine collection of PROMs within the pelvic abdominal cancer setting to improve patient quality of life and outcomes.https://doi.org/10.1186/s12955-020-01648-xPatient reported outcome measurementsHealth related quality of lifePrognostic factorsOverall survivalPelvic abdominal cancers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Miss Charlotte L. Moss Ajay Aggarwal Asad Qureshi Benjamin Taylor Teresa Guerrero-Urbano Mieke Van Hemelrijck |
spellingShingle |
Miss Charlotte L. Moss Ajay Aggarwal Asad Qureshi Benjamin Taylor Teresa Guerrero-Urbano Mieke Van Hemelrijck An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice Health and Quality of Life Outcomes Patient reported outcome measurements Health related quality of life Prognostic factors Overall survival Pelvic abdominal cancers |
author_facet |
Miss Charlotte L. Moss Ajay Aggarwal Asad Qureshi Benjamin Taylor Teresa Guerrero-Urbano Mieke Van Hemelrijck |
author_sort |
Miss Charlotte L. Moss |
title |
An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice |
title_short |
An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice |
title_full |
An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice |
title_fullStr |
An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice |
title_full_unstemmed |
An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice |
title_sort |
assessment of the use of patient reported outcome measurements (proms) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice |
publisher |
BMC |
series |
Health and Quality of Life Outcomes |
issn |
1477-7525 |
publishDate |
2021-01-01 |
description |
Abstract Background Patient reported outcome measurements (PROMs) are emerging as an important component of patient management in the cancer setting, providing broad perspectives on patients’ quality of life and experience. The use of PROMs is, however, generally limited to the context of randomised control trials, as healthcare services are challenged to sustain high quality of care whilst facing increasing demand and financial shortfalls. We performed a systematic review of the literature to identify any oncological benefit of using PROMs and investigate the wider impact on patient experience, in cancers of the pelvic abdominal cavity specifically. Methods A systematic review of the literature was conducted using MEDLINE (Pubmed) and Ovid Gateway (Embase and Ovid) until April 2020. Studies investigating the oncological outcomes of PROMs were deemed suitable for inclusion. Results A total of 21 studies were included from 2167 screened articles. Various domains of quality of life (QoL) were identified as potential prognosticators for oncologic outcomes in cancers of the pelvic abdominal cavity, independent of other clinicopathological features of disease: 3 studies identified global QoL as a prognostic factor, 6 studies identified physical and role functioning, and 2 studies highlighted fatigue. In addition to improved outcomes, a number of included studies also reported that the use of PROMs enhanced both patient-clinician communication and patient satisfaction with care in the clinical setting. Conclusions This review highlights the necessity of routine collection of PROMs within the pelvic abdominal cancer setting to improve patient quality of life and outcomes. |
topic |
Patient reported outcome measurements Health related quality of life Prognostic factors Overall survival Pelvic abdominal cancers |
url |
https://doi.org/10.1186/s12955-020-01648-x |
work_keys_str_mv |
AT misscharlottelmoss anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT ajayaggarwal anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT asadqureshi anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT benjamintaylor anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT teresaguerrerourbano anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT miekevanhemelrijck anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT misscharlottelmoss assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT ajayaggarwal assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT asadqureshi assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT benjamintaylor assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT teresaguerrerourbano assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice AT miekevanhemelrijck assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice |
_version_ |
1724335098366525440 |